Patients with CHD-PAH (p < 0.001) and patients with CTEPH (p <0.01) also had a significantly higher percentage of T cells CD4+CD200+ compared to the control group. This evidence concerns the gene CD4 and chronic thromboembolic pulmonary hypertension.